论文部分内容阅读
本文通过对3例马尔尼菲青霉患者及其他各类病例2370例的血清免疫扩散试验,证明马尔尼菲青霉具有免疫原性.人感染马尔尼菲青霉后能产生特异性抗体,病变明显者抗体效价高,病变消退后抗体效价下降,不出现病变者血清中不出现抗体.抵抗力太差的全身性广泛播散病例无抗体产生,其预后不良.非马尔尼菲青霉病患者,其中包括隐球菌、孢子丝菌和着色霉菌等深部真菌感染病例,其血清与马尔尼菲青霉抗原无交叉反应.应用免疫扩散试验对马尔尼菲青霉病有诊断和估计预后的价值.
In this paper, 3 cases of Penicillium marneffei and 2370 cases of other types of cases of serum immunodiffusion test to prove that Penicillium marneffei has immunogenicity.People infected with Penicillium marneffei can produce specific antibodies, lesions Obviously high antibody titer, the antibody titer decreased after the lesion subsided, no antibody does not appear in the serum of patients with poor resistance to the wide spread of cases of widespread antibodies without antibodies, the prognosis is not good. Non-Marneffei Penicillium Patients with deep fungal infections such as cryptococcosis, sporotrichosis and coloration mold had no serum cross-reactivity with Penicillium marneffei.Using immunodiffusion tests for the diagnosis and prognosis of Penicillium marneffei value.